Evidence map›Paper›PMID 37763636›Full record

ArticleMedicina (Kaunas, Lithuania)2023

Safe and Efficient Use of Tocilizumab in Rheumatoid Arthritis Patient on Maintenance Hemodialysis: A Case Report.

Paula Kilić, Lucija Ikić, Miroslav Mayer, Marinko Artuković, Ksenija Maštrović Radončić, Marina Ikić Matijašević

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Targeting inerleukin-6 for renoprotection.Frontiers in immunology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Paula KilićDepartment of Clinical Immunology, Rheumatology, and Pulmonology, University Hospital Sveti Duh, 10000 Zagreb, Croatia.
Lucija IkićDepartment of Anatomy and Physiology, University of Applied Health Sciences, 10000 Zagreb, Croatia.
Miroslav MayerDepartment of Internal Medicine, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Marinko ArtukovićDepartment of Clinical Immunology, Rheumatology, and Pulmonology, University Hospital Sveti Duh, 10000 Zagreb, Croatia.
Ksenija Maštrović RadončićDepartment of Physical Medicine and Rehabilitation, University Hospital Sveti Duh, 10000 Zagreb, Croatia.
Marina Ikić MatijaševićDepartment of Clinical Immunology, Rheumatology, and Pulmonology, University Hospital Sveti Duh, 10000 Zagreb, Croatia.
Klinička bolnica "Sveti Duh" · HRUniversity Hospital Centre Zagreb · HRUniversity of Applied Health Sciences · HRUniversity of Zagreb · HR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antirheumatic AgentsArthritis, RheumatoidBiological ProductsJanus Kinase InhibitorsKidney Failure, ChronicAdultAntibodies, Monoclonal, HumanizedHumansRenal DialysisAntibodies, Monoclonal, HumanizedAntirheumatic AgentsBiological ProductsJanus Kinase Inhibitorstocilizumabend-stage renal diseasehemodialysisinflammatory arthritisinterleukin-6kidney transplantationrheumatoid arthritistocilizumab

Identifiers

PMID37763636
PMCPMC10533146
OpenAlexW4386099471

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.